S100A6 and neoplasm: Indeed, treatment of cells with recombinant S100A4 may promote their motility, via interactions with growth factors or cytokines in extracellular milieu38 or via RAGE pathway stimulation.39 S100A6 was also shown to stimulate in vitro migration of tumour cells, including PDAC, but mechanistic understanding is still missing.40,41